Depression and anxiety in subjects with chronic non‑communicable diseases
Evangelista, Jéssica Maria Vieira; Soares, Viviane; Mendanha, Ludymilla Pollyana Magalhães; Oliveira-Silva, Iransé; Lima, William Alves; Ribeiro, Henrique Lima; Teixeira Junior, Jairo; Tolentino, Grassyara Pinho; Venâncio, Patrícia Espíndola Mota
Abstract
Background: Modern society is undergoing socio-cultural and economic transformations. Such changes lead to situations in which the human being has to choose between his health or practicality, directly affecting his quality of life. Pathologies with a high degree of morbidity such as depression, anxiety and chronic diseases immerse themselves in this equation, and are taking alarming proportions in society nowadays. Objectives: To identify the levels of depression and anxiety in individuals with chronic non-communicable diseases. Method: This is a cross-sectional and quantitative study, consisting of 23 young adults with 20-40 years old, hypertensive or with type 2 diabetes mellitus. The symptoms of depression and anxiety were evaluated using the Beck Depression Inventory and Beck Anxiety Inventory. Results: In hypertensive patients, the mean scores for the Depression Inventory were 15.0 and for diabetics 15.6. For the Anxiety Inventory the mean scores obtained for hypertensive patients were 11.6 and 8.1 for diabetics. For the most part, both groups were classified as without depression (43.48%) and mild depression (43.48%); And without anxiety (47.9%) and mild anxiety (34.8%). Significant differences (p = 0.050) were found only in the mean scores for the Beck Anxiety Inventory between groups. No significant differences were found between the sexes. Conclusion: We conclude that the studied sample, both hypertensive and diabetic patients, mostly present with depression and mild anxiety. And when compared between the sexes the women showed to be more vulnerable than the men.
Keywords
References
1 Brasil. Ministério da saúde. Diretrizes e recomendações para o cuidado integral de doenças crônicas não-transmissíveis: promoção da saúde, vigilância, prevenção e assistência. Brasília (DF); 2008.
2 Organização Mundial da Saúde. Prevenção de doenças crônicas: um investimento vital. Brasília (DF); 2005.
3 Lessa LR, Fontenelle L. Toxina botulínica como tratamento para fobia social generalizada com hiperidrose. Rev Psiq Clin. 2011;38(2):84-6.
4 Brasil. Ministério da saúde. Plano de ações estratégicas para o enfrentamento das doenças crônicas não transmissíveis (DCNT) no Brasil 2011-2022. Brasília (DF);2011.
5 Wijerathne B, Meier R, Agampodi T, Agampodi S. Dermatoglyphics in hypertension: a review. Journal of Physiological Anthropology. 2015;34(29).
6 Sociedade Brasileira de Cardiologia. VI diretrizes brasileiras de hipertensão. Arq Bras Cardiol. 2010;94(1 suppl):1-51.
7 Rabetti A, Freitas S. Avaliação das ações em hipertensão arterial sistêmica na atenção básica. Rev Saúde Pública. 2011;45(2):258-68.
8 Organização Mundial da Saúde. A global brief of hypertension: silent killer, global public crises. Geneva (SWZ); 2013.
9 Organização Mundial da Saúde. Global status report on noncommunicable diseases 2010. Geneva (SWZ); 2010.
10 American Diabetes Association. Classification and diagnoses of diabetes. Diabetes care. 2015;38(1 suppl).
11 Abelha L. Depressão, uma questão de saúde pública. Cad. Saúde Colet. 2014;22(3): 223.
12 Bangalore S, Gong Y, Cooper-dehoff R, Pepine C, Messerli F. 2014 eight joint national committee panel recommendation for blood pressure targets revisited. Journal of the american college of cardiology. 2014;64(8).
13 American Psychiatric Association. Manual e Diagnóstico de Transtornos Mentais DSM-5. 5 ª ed. Porto Alegre: ARTMED; 2014.
14 Apostolo JLA, Figueiredo MH, Mendes AC, Rodrigues MA. Depressão, ansiedade e estresse em usuários de cuidados primários de saúde. Rev. Latino-Am. Enfermagem. 2011;19(2).
15 Beck A, Ward C, Mendelson M, Mock J, Erbaugh J An inventory for measuring depression. American Psychological Association. 1967;4.
16 Cunha JA. Manual da versão em português das Escalas Beck. São Paulo: Casa do Psicólogo; 2001.
17 Beck A, Epstein N, Brown G, Steer R. An inventory for measuring clinical anxiety: psychometric properties. American Psychological Association. 1988; 56(6):893-897.
18 Bandelow B, Michaelis S. Epidemiology of anxienty disorders in the 21st century. Dialogues in Clinical Neuroscience. 2015;17(3).
19 Wu EL, Chien I, Lin CH. Increased risk of hypertension in patients with anxiety disorders: A population-based study. Journal of Psyshosomatic Research. 2014;77:522-27.
20 Stein DJ, Aguilar-Caxiola S, Alonso J, Bruffaerts R, Jonge P, Liu Z, et al. Associations between mental disorders and subsequent onset of hypertension. General Hospital Psychiatry. 2014;36:142-9.
21 Edwards LE, Mezuk B. Anxiety and risk of type 2 diabetes: Evidence from the Baltimore Epidemiologic Catchment Area Study. J Psychosom Res. 2012; 73(6):418–23.
22 Mauro MN, Moreira DG, Paiva SC, Lisboa FT. Incidência de depressão em pacientes diabéticos em uma unidade de saúde. An Congr Bras Med Fam Comunidade. Belém, 2013 Maio; 12:695.
23 Arshad AR, Alvi KY. Frequency of depression in type 2 diabetes mellitus and an analysis of predictive factors. J Pak Med Assoc. 2016; 66(4):425-9.
24 Rotella F, Manucci E. Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies. Diabetes Research and Clinical Practice. 2013;99:98-104.
25 Demmer RT, Gelb S, Suglia SF, Keys KM, Aiello AE, Colombo PC, et al. Sex Differences in the Association between Depression, Anxiety, and Type 2 Diabetes Mellitus. Psychosom Med. 2015;77(4):467–77.
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email